4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-16-023241
$NBYCIK 0001389545operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:04 PM ET
Size
5.4 KB
Accession
0001437749-16-023241
Insider Transaction Report
Form 4
Radaelli Massimo
Director
Transactions
- Award
Common Stock (right to buy)
2016-01-04+600→ 2,400 totalExercise: $2.02From: 2016-01-04Exp: 2026-01-04→ Common Stock (600 underlying)
Footnotes (3)
- [F1]Granted pursuant to the 2007 Omnibus Incentive Plan and the 2016 Non-Employee Director Compensation Plan
- [F2]Stock options will vest in equal monthly installments over one year starting from the date of grant
- [F3]On December 18, 2015, the common stock of NovaBay Pharmaceuticals reverse split 1-for-25, and is reflected accordingly in both the number of underlying option shares and exercise price of the award.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:04 PM ET
- Size
- 5.4 KB